Creo
United Kingdom
acquiredseries-c-plus
series-c-plus
Stage
1999
Founded
2
Investors
About
Creo is a medical technology company focused on developing advanced energy solutions for therapeutic endoscopy, including devices that utilize microwave and radiofrequency energy for minimally invasive procedures such as resection, dissection, hemostasis, and ablation in gastrointestinal, pulmonary, hepatic, and pancreatic applications.
Explore Creo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.